Inventor · disambiguated record
Fredrik P. Marmsater
Also filed as: MARMSAETER FREDRIK P · MARMSAETER FREDRIK PEHR · MARMSATER FREDRIK P · MARMSATER FREDRIK PEHR
18 granted patents·4 pending applications·56 citations·filing 2005–2022
91Inventor score
Top patents by PatentIndex Score
22 records- 0193US10780073B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2018·Granted Sep 22, 2020·7 cites·24 claims
- 0291US9693989B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2013·Granted Jul 4, 2017·13 cites·28 claims
- 0390US8648087B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesLYSSIKATOS JOSEPH P·Filed 2006·Granted Feb 11, 2014·24 cites·37 claims
- 0481US12171739B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 0577US8138181B2Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitorsALLEN SHELLEY·Filed 2008·Granted Mar 20, 2012·3 cites·29 claims
- 0675US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 0774US8557809B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Oct 15, 2013·2 cites·17 claims
- 0872US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 0971US8575145B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Nov 5, 2013·2 cites·29 claims
- 1071US2021008023A1N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 1167US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 1267US7816523B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2009·Granted Oct 19, 2010·0 cites·18 claims
- 1366US7803938B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2009·Granted Sep 28, 2010·0 cites·15 claims
- 1462US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 1560US2017252317A1N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 1658US7858646B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2005·Granted Dec 28, 2010·0 cites·23 claims
- 1758US7678794B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2005·Granted Mar 16, 2010·0 cites·19 claims
- 1857US7598423B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2005·Granted Oct 6, 2009·0 cites·23 claims
- 1953US2011184013A1Imidazo[1,2-a]Pyridine Compounds As Receptor Tyrosine Kinase InhibitorsALLEN SHELLEY·Filed 2009·Application pending·0 cites
- 2050US8895550B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 25, 2014·0 cites·22 claims
- 2148US2010144751A1IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORSARRAY BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 2244US8987251B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Mar 24, 2015·0 cites·33 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →